cabergoline has been researched along with Spinal Fractures in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araujo, B; da Costa Oliveira, M; de Azevedo Oliveira, B; Dos Santos, TM; Ferreira, NP; Ongaratti, BR; Pereira-Lima, JFS; Rech, CGSL | 1 |
D'Sylva, C; Fraser, LA; Khan, T; Van Uum, S | 1 |
1 review(s) available for cabergoline and Spinal Fractures
Article | Year |
---|---|
Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: A systematic review and meta-analysis.
Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Odds Ratio; Osteoporotic Fractures; Pituitary Neoplasms; Prevalence; Prolactinoma; Sex Factors; Spinal Fractures | 2015 |
1 other study(ies) available for cabergoline and Spinal Fractures
Article | Year |
---|---|
The acromegalic spine: fractures, deformities and spinopelvic balance.
Topics: Acromegaly; Adult; Aged; Cabergoline; Female; Fractures, Bone; Humans; Insulin-Like Growth Factor I; Lordosis; Lumbar Vertebrae; Lumbosacral Region; Male; Middle Aged; Octreotide; Prospective Studies; Spinal Fractures | 2019 |